Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2019–2024 · research · R01
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
Cullen Mitsuo Taniguchi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · research · R21
Targeting the Unique Paracaspase MALT1 to Overcome Ibrutinib Resistance in Relapsed/Refractory MCL Patients
Changying Jiang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · Academic Research
Improving the Quality of Smoking Cessation and Shared Decision-Making for Lung Cancer Screening: A Cluster Randomized Trial
Robert J Volk · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2025 · cooperative agreement · U01
Patient-Derived Models of Prostate Cancer for Personalized Medicine
Yu Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2023 · research · R01
Regulation of RNA polymerase II pausing and directionality by ATP-dependent chromatin remodelers
Blaine Bartholomew · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2023 · research · R01
Pathological flow-induced endothelial damage and plaque erosion
Jun-Ichi Abe · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
Scott Kopetz · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
Cullen Mitsuo Taniguchi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · fellowship · F32
Identifying the role of Ntrk1 in immunosuppression in Kras/p53 mutant lung cancer
Jessica Konen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
How age-dependent alterations in meiotic recombination cause chromosome mis-segregation in sperm
Francesca Cole · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · Academic Research
Therapeutic Potential of T Follicular Helper Cells for Melanoma Treatment
Roza Nurieva · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2024 · research · R01
Combating Breast Cancer Brain Metastasis by Blocking the Two-Pronged Driver Kinase Function of CDK5
Dihua Yu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
How age-dependent alterations in meiotic recombination cause chromosome mis-segregation in sperm
Francesca Cole · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · Academic Research
Regulation of CD8 T cell responses in antitumor immunity
Shao-Cong Sun · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2024 · career development · K08
The role of ARF6 in the progression of diabetic kidney disease
Jamie Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · career development · K08
The role of ARF6 in the progression of diabetic kidney disease
Jamie Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · UG1
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1
Kelly K Hunt · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
Genomic and Transcriptomic Analysis of Mammographic Density
Laurel A Habel · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · cooperative agreement · U01
Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype
Robert S Bresalier · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · career development · K08
The role of ARF6 in the progression of diabetic kidney disease
Jamie Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
A Randomized Controlled Trial of Mail-Self Stamped HPV Testing to Increase Cervical Cancer Screening Participation Among Minority/Underserved Women in an Integrated Safety Net Healthcare System
Jane R Montealegre · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Development and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging Applications
Jingfei Ma · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · research · R21
Mitigating High Grade Radiation-Induced Lymphopenia through Pretreatment Autologous Lymphocyte Infusion
Gheath Al-Atrash · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · research · R01
Strategies for Persistent Agitated Delirium in Palliative Care
David Hui · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen
Marina Y Konopleva · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac device
John Paul Christodouleas · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · research · R01
Role of E3 Ubiquitin ligase RNF133 in T cell function and tolerance
Roza Insafetdinovna Nurieva · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Patient-Derived Models of Prostate Cancer for Personalized Medicine
Yu Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · research · R21
Targeting Tankyrases to Mitigate Immunosuppression and Enhance Cancer Immunotherapy
Steven Hsesheng Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2021 · research · R21
3D Imaging of Tumor Mechanobiology Using Nanobomb Optical Coherence Elastography
Konstantin V Sokolov · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
Scott Kopetz · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · CPRIT Scholar
Recruitment of First-Time, Tenure-Track Faculty Members
Kevin Nead · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2024 · research · R01
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
Albert Koong · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2021 · fellowship · F31
The Study of Immune Effects in Gliomas Treated with Oncolytic Viruses in Combination with IDO Inhibitors
Teresa T Nguyen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · Academic Research
Deciphering the Underlying Biology and Translational Relevance of PD-L2
Michael Curran · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2024 · award
Role of aberrant enhancer activation in colorectal cancer
Kunal Rai · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2019–2025 · research · R01
Administrative Supplement: Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac device
John Paul Christodouleas · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2023 · research · R01
Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients
Guojun Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Developing Novel Therapeutic Approaches Targeting Macrophages in GBM
Y. Alan Wang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2027 · research · R01
Ph1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014)
Michael Andreeff · The University of Texas MD Anderson Cancer Center · funded by U.S. Food and Drug Administration
